Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products

2Firsts Events by 2FIRSTS
Sep.07.2024
Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT CEO Shivam Bihani shares company's journey in nicotine pouch industry, focusing on innovation and global expansion.

On September 6th, Shivam Bihani, the founder and CEO of the Indian nicotine pouch brand MYNT, shared the company's development history, market layout, and future prospects in an interview with 2Firsts. Founded 75 years ago, MYNT has been focusing on research and development and export business of nicotine pouches since entering the oral tobacco market in 2019. The company is committed to improving product taste and user experience through technological innovation.

 

The pharmaceutical background supports the layout of the nicotine pouch market

 

The predecessor of MYNT was a pharmaceutical company, which in 2019 decided to focus its energy on the nicotine pouch field. Shivam Bihani pointed out that the company's pharmaceutical experience has provided a solid foundation for the production and quality control of nicotine pouches, which is also one of the key factors that allow MYNT products to meet the strict standards of the European and American markets. The company's products are currently mainly exported to the European and American markets, as the sale of nicotine pouch products is not allowed in India. The company is optimistic about the potential for global development in the future.

 

MYNT faces strict regulatory requirements for the export of nicotine pouches. Shivam Bihani mentioned that the company had to comply with the FDA's PMTA (Pre-Market Tobacco Product Application) requirements when entering the US market, which not only consumed a significant amount of time and money, but also posed challenges for the company's global expansion. In addition to the US, MYNT also needs to adhere to export qualification restrictions in other countries, further emphasizing the importance of global compliance in the nicotine pouch industry.

 

The company's focus is on the markets in the UK and Malaysia

 

MYNT's nicotine pouch products come in two packaging forms: pouches and boxes, to meet the needs of different consumers. Shivam Bihani emphasizes that through technological innovation, MYNT is able to provide consumers with a better taste experience, which is one of the company's core competitive advantages. Additionally, the company pays attention to the design of the packaging and has obtained relevant patents for protection.

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT bagged products | Image source: 2Firsts

 

Exclusive Interview with MYNT: Targeting the Global Market and Promoting Smoke-Free Nicotine Products
MYNT box-packaged product | Image source: 2Firsts

 

During the exhibition in Malaysia, MYNT expressed a strong intention to develop global exports. Shivam Bihani revealed that the company's current focus is on the UK and Malaysian markets. He believes that as nicotine pouch products gradually become more popular worldwide, more nicotine users will be able to break the habit of smoking and reduce the health risks associated with traditional tobacco products.

 

Confidence in the Future of Nicotine Pouches

 

Shivam Bihani is confident in the future of nicotine pouches. He believes that despite being a new nicotine product like e-cigarettes, there are significant differences between the two in the market, they are very different. Nicotine pouches are becoming increasingly popular among global consumers due to their smoke-free and convenient characteristics, and they have huge market potential.

 

In regards to the company's development plan, Shivam Bihani stated that the company will continue to focus on the nicotine pouch sector and will not consider expanding into the chewing gum or other compressed product categories. In the future, they will continue to cultivate this market and provide high-quality, safe smokeless nicotine products for consumers worldwide.

 

MYNT's global strategy not only demonstrates the potential of Indian companies in the nicotine pouch field, but also provides new ideas for the global development of the nicotine pouch industry.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece have opposed Ireland’s proposed nicotine product regulations, arguing that the measures could affect EU market coordination and the free movement of products. Ireland plans to introduce stricter rules covering nicotine products including vapes and nicotine pouches, with measures involving packaging, marketing and sales controls. The dispute highlights differences among EU member states between stronger public health protections and maintaining regulatory consistency within the bloc’s single market.
Jul.29
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives